Symptom overlap in anxiety and multiple sclerosis
- 14 February 2013
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 19 (10) , 1349-1354
Abstract
Background: The validity of self-rated anxiety inventories in people with multiple sclerosis (pwMS) is unclear. However, the appropriateness of self-reported depression scales has been widely examined. Given somatic symptom overlap between depression and MS, research emphasises caution when using such scales. Objective: This study evaluates symptom overlap between anxiety and MS in a group of 33 individuals with MS, using the Beck Anxiety Inventory (BAI). Methods: Participants underwent a neurological examination and completed the BAI. Results: A novel procedure using hierarchical cluster analysis revealed three distinct symptom clusters. Cluster one (‘wobbliness’ and ‘unsteady’) grouped separately from all other BAI items. These symptoms are well-recognised MS-related symptoms and we question whether their endorsement in pwMS can be considered to reflect anxiety. A modified 19-item BAI (mBAI) was created which excludes cluster one items. This removal reduced the number of MS participants considered ‘anxious’ by 21.21% (low threshold) and altered the level of anxiety severity for a further 27.27%. Conclusion: Based on these data, it is suggested that, as with depression measures, researchers and clinicians should exercise caution when using brief screening measures for anxiety in pwMS.Keywords
This publication has 26 references indexed in Scilit:
- Assessment Of Depression In Multiple Sclerosis: Development Of A “Trunk And Branch” ModelThe Clinical Neuropsychologist, 2010
- Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patientsMultiple Sclerosis Journal, 2009
- Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptomsJournal of the International Neuropsychological Society, 2008
- Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapyNeurological Sciences, 2005
- The effects of anxiety on psychiatric morbidity in patients with multiple sclerosisMultiple Sclerosis Journal, 1999
- The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosisMultiple Sclerosis Journal, 1999
- The Beck Anxiety Inventory in a non-clinical sampleBehaviour Research and Therapy, 1995
- Relationship between the beck anxiety inventory and the Hamilton anxiety rating scale with anxious outpatientsJournal of Anxiety Disorders, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983